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ABSTRACT 
Surʻat-e-Inzāl (Premature Ejaculation) is the most prevalent male sexual dysfunction affecting 25 - 40% global population of men. It is a 
universal disorder and is independent of age, social or marital status.  It has a significant impact on both- patients and their partners, causing 
distress, anxiety and relationship difficulties affecting the quality of life. Several aetiologies have been proposed by various researchers which 
are not evidence-based but speculative. Accordingly the International Society for Sexual Medicine (ISSM) issued treatment guidelines for 
Premature Ejaculation (PE) recommending Serotonergic Antidepressants (SSRIs) and Local Anaesthetics (LA) for its management in modern 
medicine. However, these treatments were not actually developed for PE, and have limitations associated with their off-label use. Furthermore, 
nearly all the recommended drugs have a wider spectrum of adverse effects and serious drug interactions which sometimes could be fatal. On 
the other hand, centuries old Unani medicine offers a complete line of treatment for Surʻat-e-Inzāl based on traditional knowledge and 
experience. Firstly, various single as well as compound Unani formulations have been in use since long for the treatment of Surʻat-e-Inzāl and 
found effective and safe. Secondly, the benefits of herbal and other natural products are increasingly being sighted because of their lesser side 
effects. Keeping the limitations and adverse effects posed by conventional treatment of PE in mind, an attempt has been made in this paper to 
review the use of age old Unani System of Medicine for the treatment and management of Premature Ejaculation. 
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Introduction 
The history of premature ejaculation (PE) is probably as 
old as human history. Despite the well known history of 
PE in the 19th and 20th centuries, there is a little 
information on the history of this disease throughout 
antiquity and medieval period. PE is mentioned in ancient 
Greek mythology as “ejaculation ante portas.” It appears 
that medieval Unani physicians have mentioned PE in 
their medical manuscripts for the first time [1]. Surʻat-e-
Inzāl is an Arabic term consisting of two words; Surʻat 
means hastiness and Inzāl means emission of semen, hence 
the term Surʻat-e-Inzāl stands for premature ejaculation. 
In classical Unani medicine it is defined as a condition in 
which ejaculation of semen takes place immediately after 
insertion or during foreplay itself before insertion of 
penis. Sometimes it occurs merely due to sexual fantasies 
and even on friction with clothes [2,3]. According to 
classical Unani literature reproductive functions related to 
the generation of “Mani” or semen (sperm and ovum) 
depend on Al Quwa-e-Tanasuliya (reproductive faculty). 
However, Quwat-e-Bah (Faculty of sexual potency and 
libido) governs sexual functions and carries the meaning of 
virility, lust, venereal passion and generative poser. This 
faculty namely Quwat-e-Bah depends upon the overall health 
and normal functioning of four vital organs viz. brain, heart, 
liver and testes. Any pathological condition affecting 
adversely any of these organs results in Surʻat-e-Inzāl or 
premature ejaculation [4]. According to renowned Unani 
scholar Hakim Ajmal Khan Surʻat-e-Inzāl when 
accompanied by Zof-e-Bah (sexual debility) causes 
embarrassment, distress, relationship difficulties and 
suicide-attempts in males [5].  
PE is the most prevalent male sexual dysfunction according 
to the results of numerous epidemiological studies 
[6,7,8,9,10]. Estimating the prevalence of PE is not 
straightforward due to difficulty in defining what constitutes 
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clinically relevant PE. Overall, the prevalence rate of PE 
falls somewhere between 25 and 40% in the global 
population of men across all age groups [11,12,13]. 
However, past data on the overall prevalence of PE are 
varied, in great part due to the lack of prior 
standardization of the definition of PE and criteria for 
patient enrolment in epidemiological studies. Some 
authors have reported prevalence rates as low as 4% and 
as high as 66% [14,15,16].  
Results from the National Health and Social Life Survey 
(NHSLS), a large study of sexual behaviour in a 
demographically representative sample of adults in the 
United States, indicate a prevalence rate of 29%. The 
NHSLS surveyed 1410 men in the United States between 
the ages of 18 and 59 years. Similar findings are reported 
in the more recent Global Study of Sexual Attitudes and 
Behaviours (GSSAB), a large, survey-based study where 
the prevalence of common sexual dysfunctions was 
studied in 29 countries, which were stratified into seven 
geographic regions. The majority of the prevalence rates 
reported in these seven regions were very similar to the 
prevalence rate reported by the NHSLS, with four of the 
seven regions reporting prevalence rates from 27.4 to 
30.5%. One notable exception was that in the Middle East 
region, a prevalence rate of 12.4% was reported. The 
highest recorded prevalence occurred in Southeast Asia 
(30.5%). Men with PE are more likely to report lower level 
of sexual functioning and satisfaction, and higher level of 
personal distress and interpersonal difficulty than men 
without PE. In addition, their partner’s satisfaction with 
the sexual relationship has been reported to decrease with 
increasing severity of the condition [13]. 
Definition  
WHO describes PE as “the inability to delay ejaculation 
sufficiently to enjoy love making, which is manifested by 
either an occurrence of ejaculation before or very soon after 
the beginning of intercourse or ejaculation occurs in the 
absence of sufficient erection to make intercourse 
impossible.” 
The American Urological Association (AUA) defines it as 
ejaculation that “occurs sooner than desired, either before or 
shortly after penetration, causing distress to either one or 
both partners.” 
The Second International Consultation on Sexual and 
Erectile Dysfunction defined PE as ‘ejaculation with minimal 
stimulation and earlier than desired, before or soon after 
penetration, which causes bother or distress, and over which 
the sufferer has little or no voluntary control’ [17]. 
The International Society for Sexual Medicine (ISSM) has 
adopted a completely new definition of PE which is the first 
evidence based definition, “Premature ejaculation is a male 
sexual dysfunction characterized by ejaculation which always 
or nearly always occurs prior to or within about one minute of 
vaginal penetration; and inability to delay ejaculation on all 
or nearly all vaginal penetrations; and negative personal 
consequences, such as distress, bother, frustration and/or the 
avoidance of sexual intimacy”.   
It must be noted that this definition is limited to men with 
lifelong PE who engage in vaginal intercourse since there are 
insufficient objective data to propose an evidence-based 
definition for acquired PE [18]. 
All definitions have taken into account the time to 
ejaculation, the inability to control or delay ejaculation, and 
negative consequences (bother/distress) from PE. However, 
the major point of debate is quantifying the time to 
ejaculation, which is usually described by Intravaginal 
Ejaculatory Latency Time (IELT).The recommended 
ejaculatory latency time for diagnosing PE has varied in 
the literature from 1 to 2 minutes or less 
[19]. Importantly, no widely accepted standard for 
‘normal’ ejaculatory latency exists. However, a recently 
published study by Patrick et al on a large community-
based population of men and their partners revealed that 
the median Intravaginal Ejaculatory Latency Time, 
recorded using a partner-held stopwatch, was 7.3 minutes 
for men without PE and 1.8 minutes for men with PE 
[20,21]. 
Classification 
Premature ejaculation is classified as ‘lifelong’ (primary) or 
‘acquired’ (secondary). Lifelong PE is characterized by onset 
from the first sexual experience, remains so during life and 
ejaculation occurs too fast (before vaginal penetration or < 
1-2 min after). Acquired PE is characterized by a gradual or 
sudden onset following normal ejaculation experiences 
before onset and time to ejaculation is short (usually not as 
short as in lifelong PE). In most cases, acquired premature 
ejaculation is easier to treat and has a better prognosis [22].  
Recently, two more PE syndromes have been proposed: 
Natural variable PE is characterized by inconsistent and 
irregular early ejaculations, representing a normal variation 
in sexual performance. Premature-like ejaculatory 
dysfunction is characterized by subjective perception of 
consistent or inconsistent rapid ejaculation during 
intercourse, while ejaculation latency time is in the normal 
range or can even last longer. It should be regarded as a 
symptom or manifestation of a true medical pathology. The 
addition of these new types may aid patient stratification, 
diagnosis and treatment, but their exact role remains to be 
defined [23,24,25,26].  
Aetiology and Diagnosis 
Most of the proposed aetiologies are not evidence-based but 
speculative. Psychological theories include the effect of early 
experience and sexual conditioning, anxiety, sexual 
technique, the frequency of sexual activity and 
psychodynamic explanations. Biological explanations 
include evolutionary theories, penile hypersensitivity, 
central neurotransmitter levels and receptor sensitivity, 
degree of arousability, the speed of the ejaculatory reflex 
and the level of sex hormones [27]. Premature Ejaculation 
Diagnostic Tool (PEDT) is the most widely used tool for the 
diagnosis of premature ejaculation. However, there is a low 
correlation between a diagnosis provided by PEDT and a self 
reported diagnosis. A recent study reported that only 40% of 
men with PEDT diagnosed PE and 19% of men with 
probable PE self reported the condition [28]. A sexual health 
survey conducted by the Turkish Society of Andrology 
reported that although the sensitivity value of PEDT was 
89.3%, but the specificity value was only 50.5% [29].  
Unani Concept 
The concept of premature ejaculation as a disease was first 
described by prominent Hakim Ismail Jurjani. Although his 
predecessor great Unani scholar Ibn-e-Sina, addressed a 
disease “Kasrat-e-Daura-e-Mani” (excessive semen gush), 
some symptoms of which were similar to PE. However, 
Jurjani reported several important points, which were not 
previously addressed by Ibn-e-Sina [1]. Scholars of the late 
era like Hakim Akbar Arzani, Hakim Azam Khan etc. 
advocated the view of Jurjani and mentioned numerous 
“Asbab-e-Marz” (pathological causes) which are summarized 
as follows:   
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 Zakawat-e-Hiss (Hypersensitivity) is the major cause of 
Surʻat-e-Inzāl in which a minor stimulus or sexual 
thought may provoke ejaculation. It occurs due to Jalaq 
(masturbation), Aghlaam (anal-sex), indulgence in 
excessive intercourse, pornography, sexual fantasies; 
over use of ‘Tila-e-Mulazziz’ i.e. pleasure enhancing 
lotions etc. [2,5,30,31,32].  
 Zof-e-Quwwat-e-Masika (debility in retentive power) 
causes flaccidity of Auiya-e- Mani i.e. testicular 
ducts, vessels, smooth muscles etc. It occurs due to 
predominance of Burudat and Rutubat (Cooling & 
Wetness) in the male reproductive organs because 
of exposure to cold, wet or moist conditions for long 
[2, 3, 29,30, 31, 33, 34, 35,36,37].  
 Hiddat-e-Mani (acuteness of semen) occurs in 
patients having Damvi or Sanguine temperament due 
to predominance of sanguinous humor. Other causes 
may include hot climate, jobs dealing with heat, hot 
inflammations of seminal vessels etc. [2, 3, 30,31, 32, 
33, 34, 35, 36,37].  
 Kasrat-e-Mani (excessive semen volume) either due 
to abstinence from intercourse for long or over 
consumption of Mowallid-e-Mani (Seminopoietic) 
substances. This is frequently accompanied with 
Ghalba-e-Khilt-e-Dam (predominance of sanguinous 
humor). However, it is comparatively a less common 
cause of Surat-e-Inzal [3,5, 30,31, 32, 33, 34,35,36,37].  
 Riqqat-e-Mani (low viscosity of semen) due to 
predominance of Burudat and Rutubat (Coldness & 
Wetness) in the testicular ducts or vessels. Other 
causes may include-citrus foods and drinks, 
excessive coitus, masturbation, nervine debility etc. 
[2, 31, 32, 34,37,38].  
 Zof-e-Aza-e-Raisa i.e. debility of vital organs – Heart, 
Brain, Liver and / or Testes results in premature 
ejaculation often accompanied with sexual debility 
(Zof-e-Bah) and vice-versa [2, 3, 30,31,32, 33, 34, 35, 
36,37].  
 Ittisa-e-Majari-e-Qazeeb (Dilatation of penile vessels 
and ducts including Urethra), due to Gonorrhoea, 
excessive intercourse, catheterization etc. [3, 30,31,32, 
33, 35, 36,37].  
 Other causes: Anxiety, inexperience, excessive sexual 
thoughts, guilt associated with masturbation, 
abnormalities in prepuce, too narrow vagina, renal and 
bladder stones or injuries, intestinal worms, 
haemorrhoids, Gonorrhoea etc. [3,5,30].  
Tashkhees-e-Marz (Diagnosis) 
 In Unani medicine diagnosis of Surʻat-e-Inzāl (PE) is 
based on various sign and symptoms mentioned in 
the classical text which are summarized in Table-1 [2, 
32,36]. 
 
Table-1:  Diagnosis based on classical sign and symptoms 
Classical Sign and Symptoms Unani Pathology  
 
 Colour of seminal fluid may be white 
 Consistency may be thin without any sign of hotness 
 Quantity of ejaculated semen may be  excessive 
Zof-e-Quwwat-e-Masika (Debility in 
Retentive power) 
 Both colour and consistency of seminal fluid may be Motadil (normal)  
 Both libido and sexual power may be in abundance 
 Full erection may be present during coitus 
 Intercourse may not  result any sluggishness or exhaustion 
 Frequent nocturnal emission may take place 
 Body complexion of the patient may be red 
 History of abstinence from intercourse may be present 
 History of use of Muwallid-e-Mani (seminopoietic substance) may be present 
Kasrat-e-Mani  
(Excessive semen volume) 
 Colour of seminal fluid may be yellowish 
 Consistency may be light and thin 
 Burning sensation may take place during ejaculation   
Hiddat-e-Mani  
(Acuteness of semen) 
 Zof-e-Bah (sexual debility) may be present alongwith sign and symptoms of  
Zof-e-Aza-e-Raisa (debility of vital organs) 
Zof-e-Aza-e-Raisa  
(Debility of vital organs) 
 Dilatation of urethra may occur as a result of Gonorrhoea, masturbation 
and excessive coitus.  
 Ittisa-e-Majari-e-Qazeeb (Dilatation of 
penile vessels and ducts including Urethra)  
 If premature ejaculation occurs during intromission 
 Zof-e-Quwwat-e-Masika-wa-Istarkha-e-
Auiya-e Mani (debility in Retentive power 
and flaccidity of testicular ducts/vessels) 
 Zakawat-e-Hiss (Hypersensitivity) of genital 
organs and nerves 
 Ittisa-e-Majari-e-Qazeeb (Dilatation of 
penile vessels and ducts including Urethra)  
 If premature ejaculation occurs along with erectile dysfunction and decreased 
libido 
 Zof-e-Dimagh (Cerebroasthenia) 
 Zof-e-Asaab (Nervine debility) 
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Usool-e-Ilaj (Principle line of treatment) 
Principle line of treatment in Surʻat-e-Inzāl can be set forth 
in the following manner: 
I. To relieve symptoms and signs 
a. Zakawat-e-Hiss (Hypersensitivity): Oral as well as local 
use of anaesthetic and sedative drugs [2, 31, 32].  
b. Zof-e-Quwwat-e-Masika (debility in Retentive 
power): Oral use of semen retentive drugs and 
measures [2, 31, 32, 34, 35, 36].  
c. Hiddat-e-Mani (acuteness of semen): Administration 
of Tabreed either orally or locally with cooling agents 
[2, 31, 32, 34, 35, 36].  
d. Kasrat-e-Mani (Excessive semen volume): Oral use of 
semen reducing drugs and measures [31, 32, 34, 35, 
36].  
e. Ghalba-e-Khilt-e-Dam (predominance of sanguinous 
humor): Application of Fasd with dietary control & 
other measures [31,32,34,35].  
f. Riqqat-e-Mani (thin consistency of semen): Oral use of 
drugs inspissant to semen      [31,32,34].  
g. Zof-e-Aza-e-Raisa (vital organs’ debility): Oral use of 
tonics for strengthening vital organs in particular and 
body in general [2,31,32,34,35, 36].  
h. Ittisa-e-Majari-e-Qazeeb (dilated penile vessels): 
Oral as well as local use of astringents [31,32,36].  
II. Ta’deel-e-Mizaj (correction of deranged temperament)  
Tanqiya-e-Madda / Istafraghat-e-Madda (evacuation of 
morbid material) via Fasd (bloodletting), Hijamah (cupping), 
Muqqiyat (emetics) and Mus’hil (purgatives) [2,31,32,34,35, 
36,37].  
III. Talayyin-e-Shikam (laxation of bowel) 
Mulayyianat (Laxatives) are used in order to correct the 
constipation induced as a result of Mughallizat and 
Musakkinat drugs [2].  
IV. Strengthening of Quwat-e-Mudabbira-e-Badan 
(medeatrix nature) via followings: [2,31,37].  
 Tabreed (Cooling) 
 Tad’heen (Oil massage);  
 Takmeed (Hot fomentation)  
 Tila (Liniment) 
 Dalak (Massage)  
 Huqna (Enema)  
 Zarooq (Syringing) 
 Aabzan (Sit’s bath) 
 Nutool (Irrigation/pouring of decoction of drugs) 
Management 
The main principles of treatment in Unani system of 
medicine include Ilaj Bil Ghiza (dieto-therapy), Ilaj Bit 
Tadbeer (regimenal therapy) and Ilaj Bid Dawa 
(pharmacotherapy). All the said principles are 
recommended for the treatment of Surʻat-e-Inzāl. The aim 
of treatment of the patients with Surʻat-e-Inzāl is to delay 
the ejaculation by achieving voluntary control. Treatment 
modalities consist of internal and external use of specific 
drugs for restoration of lost powers, correction of deranged 
temperament, elimination of morbid humours, and 
strengthening of organs, muscles and nerves. In addition, a 
proper regime regarding diet should be followed besides the 
abstinence from food which aggravates the disease. Various 
measures of treatment mentioned in Unani literature for the 
management of Surʻat-e-Inzāl can be summarized as under: 
I. In case of causative factor being Zakawat-e-Hiss 
(Hypersensitivity) Mukhaddirat and Musakkinat 
(Anaesthetic and Sedative) are recommended as main 
line of drugs.  
 Elimination of the causative factors is essential before 
commencing the drug therapy. 
 Deformities of masturbation should be treated with 
exclusive therapies viz. Tad’heen (Oil massage); 
Takmeed (Hot fomentation) and Tila (Liniment) in the 
same order.  
 Adequate nourishment must be supplied in order to 
maintain Badl-ma-Yathal’lal (replacement of bodily 
nutrients). Specific attention should be given towards 
the improvement of digestion and bowel movements. 
 Restoration of health of vital organs viz. Heart, Brain, 
Liver and Testes is mandatory.  
 Various procedures under Ilaj-bit-Tadbir have been 
described to reduce  the hypersensitivity such as 
Nutool (Irrigation) over genital organs with Alum  
water; Aabzan (Sitz bath) in cold water;  Zarooq 
(Syringing) of Joshanda Koknar into Urethral orifice are 
some extremely useful methods in reducing 
hypersensitivity [2, 31,32].  
II. In case of causative factor being Zof-e-Quwwat-e-
Masika (debility in Retentive power) Mumsikat-e-
Mani (Semen retentive) are indicated as main line of 
drugs. 
 Tanqiya-e-Balgham (Evacuation of phlegm) either with 
Qai (emesis) or Is’haal (purgation) is recommended 
first before using main line of drugs. Iyarijat are 
exclusively beneficial for phlegmatic purgation. 
However, Qai is preferred if possible.  
 Later on semen retentive drugs with Qabiz –Yabis 
properties should be given orally. 
 Dalak (Massage) with Tila-e-harra (hot temperament 
liniment) e.g. Roghan-e-Qust, Roghan-e-Aas, Roghan-e-
Nargis etc. should be applied at perineum and 
surroundings [2, 31,32,34,35, 36,37]. 
III. In case of causative factor being Hiddat-e-Mani 
(acuteness of semen) Tabreed (Cooling) is done with 
Barid-Ratab (cold & wet) class of drugs. These drugs 
may be given either orally, locally or both.  
 Elimination of causative factors before commencing 
drugs is essential in its management.  
 If it is due to the predominance of Sanguinous humor 
(Ghalba-e-khilt-e-Dam); then Fasd (Bloodletting) or 
Hijamah (Cupping) should be applied as a first line of 
treatment before drugs [2,31,32,34,35,36,37].  
IV. In case of causative factor being Kasrat-e-Mani 
(Excessive semen volume) Muqillate / Qaty Mani 
(semen reducing) drugs are used to reduce the 
production of semen alongwith following measures:   
[31,32,34,35, 36,37].  
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 Fasd (Bloodletting) or Hijamah (Cupping) should be 
applied as a first line of treatment if it is accompanied 
with Ghalba-e-khilt-e-Dam as mentioned earlier.  
 If it is because of long abstinence from coitus then 
frequent intercourse may be advised. 
 Taqlil-e-Ghiza (dietary control) with restriction of 
seminopoietic (Muwallid-e-Mani) substances is 
recommended. 
 Frequent Hammam (Turkish bath), Riyazat (exercise) 
and, sleep-deprivation are also advised in such cases.  
V. In case of causative factor being thin consistency of 
seminal fluid i.e. Riqqat-e-Mani (Thin/watery semen) 
Mughallizat-e-Mani (Inspissant to semen) drugs are 
recommended. Rest of the treatment is similar as 
described in Zof-e-Quwwat-e-Masika [31,32, 34]. 
VI. In case of causative factor being Zof-e-Aza-e-Raisa 
(vital organs debility) Muqawwiat-e-Azae Raisa drugs 
(Tonics for vital organs) are indicated for toning up of 
related organ. Depending upon the weakness of vital 
organ involved Muqawwi-e-Qalb (Cardio-tonics), 
Muqawwi-e-Dimagh (Brain-tonics) or Muqawwi-e-Jigar 
(Liver-tonics) are used in the management.  
 Tadeel-e-Mizaj (correction of deranged temperament) 
and Tanqiya-e-Mawad (evacuation of morbid material) 
of vital organs are essential before commencement of 
Muqawwiat drugs [2,31,32,34,35,36,37]. 
VII. In case of Ittisa-e-Majari-e-Qazeeb i.e. dilated penile 
vessels or ducts including Urethra, Qabiz 
(Astringent) drugs are indicated for oral or local 
use. Compound formulations e.g. Majoon Band 
Kushaad, Safoof Band Kushaad are the drugs of 
choice for this pathological condition. Causative 
factors like Gonorrhoea should be treated first 
before prescribing above drugs [31,32,36]. 
Ilaj Bil Ghiza (Dieto therapy) 
 Zakawat-e-Hiss & Hiddat-e-Mani: Aghziya Barida 
Rataba i.e. vegetables like Pumpkin, Ridge Gourd, 
Spinach and Pulses, Rice with Butter milk, Barley water 
or Sheera tukhm-e-khashkhaash etc are recommended. 
Foods like Meat, Fish, Alcohol, Tea, Spices, red Chillies, 
citrus and fried items are strictly prohibited.  
 Jalaq: Simple and easily digestible diet composed of 
vegetables e.g. Spinach, Pumpkin, Ridge Gourd, and 
pulses is recommended. Cold and Citrus food items are 
prohibited. Use of cold water on genitals is harmful in 
Jalaq. 
 Zof-e-Quwwat-e-Masika & Riqqat-e-Mani: Egg yolk, 
Honey, bird’s meat cooked with Satar, Zeera and 
Darchini is recommended. Aghziya Rataba i.e. foods 
with high water content e.g. Pumpkin, Ridge Gourd, 
Spinach and cold, citrus food and drinks must be 
avoided.   
 Kasrat-e-Mani & Ghalba-e-khilt-e-Dam: Taqlil-e-Ghiza 
(Dietary control) is beneficial only when body’s health 
and strength  are adequate. Muqillate Mani Aghziya e.g. 
Beet root, Kahoo, Spinach, Pulses cooked with vinegar, 
dry Coriander, Mint, Zeera, Satar and Suddab are 
recommended. Aghziya Hamiza e.g. Pomegranate or 
Tangerine juice or Sikanjbeen should also be added in 
the diet. Foods containing Meat, dairy products like -
Milk or Ghee, Seminopoietic substances and Wine are 
prohibited [2,31,32,34,35, 36,37].  
Ilaj Bit Tadbeer (Regimenal therapy) 
Ilaj Bit Tadbeer is basically application of certain special 
techniques or physical methods of treatment to improve the 
constitution of body by removing waste materials and 
improving the defense mechanism of the body. Some 
therapies are effective in Surʻat-e-Inzāl like:  
 Hijamah (Cupping)   
 ijāmah is literally derived from an Arabic word ‘ ajm’ 
which stands for volume, but technically used for “to suck”. 
It is a technique in which a cup is applied over the surface of 
skin by creating vacuum, and it is known as dry cupping 
( ijāmat  ilā Shurt). Sometimes, scarification is done at the 
location of cupping to draw blood from the body part to 
relieve internal congestion, and this process is known as wet 
cupping ( ijāmat  il Shurt) for evacuation of morbid matter 
from affected body part. For premature ejaculation wet 
cupping is recommended in between shoulders and at lower 
back followed by Dalak (massage) with salt containing 
medicaments [39]. 
 Fasd (Bloodletting)  
 a d is a method of absolute elimination (Istifrāgh Kullī), 
used to remove the excess of humours or to get rid of 
morbid matter (Mawād  āsida) from the body. In this 
procedure, an incision is given to the superficial veins and 
blood is allowed to flow. In premature ejaculation, Basilic 
vein incision is preferably given if indicated [32,35,37].  
 Nutool (Irrigation) 
Nutool is a novel method in which water, oil, or medicated 
decoction is poured from a height over specific sites of body. 
It also enhances the local absorption of medicines thus helps 
in getting the desired action of medicine locally [2, 31].  
 Ilaj Bid Dawa (Pharmacotherapy)  
A number of natural agents were identified to treat different 
causative factors involved in the disease. Unani scholars 
classified these natural drugs on the basis of their mode of 
action. Different class of drugs are indicated in different 
pathological conditions and sometimes two or more class of 
drugs are used simultaneously. A large number of drugs, 
either single or in compound formulations, have been 
mentioned in the context of the treatment of Surʻat-e-Inzāl 
[2, 40]. Most commonly used drugs are given as under: 
I. Mukhaddirat wa Musakkinat (Anaesthatics & 
Sedatives): These are the agents used to decrease the 
irritation and burning of nerves, prostrate and vas deferens 
etc. owing to their febrifuge, anaesthetic and nervine 
sedative actions [40].  
i. Mufradat (Single drugs) 
Afyun /Koknar/ Tukhm-e-Khashkhash (Papaver somniferum 
Linn.), Ajwain Khurasani (Hyoscyamus niger Linn.), Asrol 
(Rauvolfia serpentina Benth. ex. kurz.), Barg-e-Qinnab 
(Cannabis sativa Linn.), Bazr ul Banj (Hyocyamus albus 
Linn.), Isapghol (Plantago ovata Forsk.), Kafoor 
(Cinnamomum camphora Linn.), Kishneez (Coriandrum 
sativum Linn.), Raughan-e- Khar-e-Khasak (Tribulus 
terrestris Linn.), Sandal safaid (Santalum album Linn.), 
Tukhm-e-Kahu (Lactuca scariola Linn.), Tukhm-e-Dhatura 
(Datura stamonium Linn.), Shibb-e-Yamani (Aluminium 
Hydroxide)  [2,40].  
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ii. Murakkabat (Compound formulations) 
Majoon-e-Zakawat-e-Hiss, Habb-e-Zakawat-e-Hiss, Safoof 
Zakawat-e-Hiss, Roghan Zakawat-e-Hiss, Habb-e-Ambar, 
Habb-e-Filfil, Dawa-al-Shaa’, Safoof Asal-us-Soos [2,40].  
II. Mumsikat-e-Mani (Semen retentive): These are the 
agents which obstructs and delays discharge of semen. Such 
drugs are anaesthetics in action and decrease sensitivity 
when administered orally or applied locally. In case of 
hypersensitivity of genital organs simply immersion of 
genital organs or body up-to umbilicus in decoction of such 
drugs helps. Generally, in premature ejaculation Mumsik 
drugs are used but unjustified prolong use of these drugs is 
harmful for potency. Hence proper interpretation of disease 
condition with underlying cause should be given before 
selection of such drugs [40].  
i. Mufradat (Single drugs) 
Aaqarqarhaa (Anacyclus pyrethrum DC.), Abrak (Silicate of 
Alumina with Magnesia), Afyun (Papaver somniferum Linn.), 
Ajwain Khurasani (Hyoscyamus niger Linn.), Azaraaqi 
(Strychnos nux-vomica Linn.), Beejband (Rumex maritimus 
Linn.), Ispand Sokhtani (Peganum harmala Linn.), Jast (Zinc), 
Mochras (Salmalia malabarica (DC) Schott & Endl.), Qaranfal 
(Syzygium aromaticum Linn.), Samagh-e-Dhak (Butea 
frondosa Roxb.), Shingaraf (Compound of Mercury and 
Sulphur), Seemab (Hydrargyrum/Mercury), Tukhm-e-
Dhatura (Datura stramonium Linn.), Tukhm-e-Qinnab 
(Cannabis sativa Linn.), Tukhm-e-Tamar Hindi (Tamarindus 
indica Linn.), Usrub (Plumbum/Lead), Utangan (Blepharis 
edulis Pers.) [2,40].  
ii. Murakkabat (Compound formulations) 
Majoon Khabsul Hadeed, Majoon Muqawwi Mumsik, Majoon 
Falak Sair, Majoon Jalali, Majoon Ispand Sokhtani, Majoon 
Nakchikni , Itrifal Kishmishi, Kushta Qalai , Kushta Usrub,  
Habbe Mumsik , Habbe Nishat , Habbe Khush Kaif,  Habbe 
Shingraf,  Habbe Joz Masal, Habbe Keemyae Ishrat, Roghan 
Qust, Roghan Nargis, Roghan Zafran [2,40].  
III. Mughallizat-e-Mani (Inspissant to semen): These are 
the agents used to increase the thickness of semen and delay 
the discharge. All Mughallizat-e-Mani are Musakkin 
(Sedative) in action [40].  
i. Mufradat (Single drugs) 
Asgand (Withania somnifera Linn.), Asrol (Rauvolfia 
serpentina Benth. ex. kurz.), Beejband (Rumex maritimus 
Linn.), Isapghol (Plantago ovata Forsk.), Lodh Pathani 
(Symplocos racemosa Roxb.), Musli Safaid (Chlorophytum 
arundinaceum Baker.), Musli Siyah (Curculigo orchioides 
Gaerth.), Samagh-e-Dhak (Butea frondosa Roxb.), Sataawar 
(Asparagus racemosus Willd.), Shaqaaqul Misri (Pastinaca 
secacul Linn.), Talmakhaana (Asteracantha longifolia Nees.), 
Tukhm-e-Kahu (Lactuca scariola Linn.), Tukhm-e-Siras 
(Albizia lebbeck (Linn.)Willd.), Tukhm-e-Tamar Hindi 
(Tamarindus indica Linn.) [2,40].  
ii. Murakkabat (Compound formulations) 
Kushta Qalai, Kushta Jast , Kushta Nuqra, Kushta Sadaf, 
Kushta Post Baiz Murgh, Kushta Musallas,  Kushta Seh Dhata 
(Musallas), Majoon Mughalliz, Majoon Arad Khurma , Majoon 
Mochras , Majoon Supari Pak, Majoon Nakchikni, Laboob e 
Kabir, Safoof Salab, Safoof Gond Kateera , Safoof Kushta 
Qalai, Safoof Saboos-e-Ispghol, Safoof Mughalliz [2,40].  
IV. Muqawwiat-e-Azae Raisa (Tonics for vital organs): 
These are the agents which strengthens the four vital organs 
viz. Heart, Brain, Liver and Testes.  For treating the disease it 
is essential to treat the weakness of these organs through 
the use of specific Cardio-tonics, Brain-tonics, Liver tonics 
and Spermatogenics depending upon the cause [40]. 
i. Mufradat (Single drugs) 
Aamla (Emblica officinalis Gaertn.), Oood Hindi (Aquilaria 
agallocha Roxb.), Chobchini (Smilax china Linn.), Gaajar 
(Daucus carota Linn.), Gaozaban (Borago officinalis Linn.), 
Gul-e-Ward (Rosa damascena Mill.), Jadwar (Delphinium 
denudatum Wall.), Marwareed (Mytilus margaritiferus), 
Mushk (Moschus moschiferus), Post Turanj (Citrus medica 
Linn.), Qust (Saussurea lappa (Decne) Sch.-Bip.), Rudanti 
(Cressa cretica Linn.), Zaafran (Crocus sativus Linn.), Zahar 
Mohra (Bezoar stone), Zamarrud (Emerald) [2,40]. 
ii. Murakkabat (Compound formulations) 
Majoon Maroohul Arwah, Khamira Abresham Arshad Wala, 
Khamira Marwareed, Dawul Misk, Tiryaq e Farooq, Hareerah 
Muqawwi Dimagh, Majoon Muqawwi Dimagh, Majoon 
Falasfa, Khamira Gaozaban Ambari Jawahar, Habbe Ambar 
Momiyai, Jawarish Jalinoos, Kushta Khabsul Hadeed , Kushta 
Mirgang, Habbe Kabid Naushadri Khas, Anushdaru [2, 40].  
V. Mulaiyanat (Laxatives): Musakkinat and Mughallizat-e-
Mani drugs generally cause constipation; therefore laxatives 
are always given alongwith these drugs. Isapghol (Plantago 
ovata), Murabba Halela (Terminalia chebula) and Itrifal 
Mulayyin are some of them [2,40].  
Conclusion 
It may be concluded that ancient Unani physicians were 
aware of the disease premature ejaculation. Based on their 
knowledge and experience they deviced a complete 
management plan and successfully treated the disease using 
natural agents. In recent years great emphasis has been laid 
on the utilization of natural agents in the management of 
various diseases due to harmful effects posed by the 
synthetic drugs. Therefore, this centuries old natural way of 
treatment must be explored further to provide an alternative 
and better treatment for premature ejaculation. 
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